Trial intelligence / Profile preview

SCCS Polypill Pilot Trial

NCT02278471Phase 2Completed

Sponsor
Vanderbilt University
Start
Dec 2015
Primary completion
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of atorvastatin, amlodipine, losartan and hydrochlorothiazide in hypertension (HTN) and hyperlipidemia, sponsored by Vanderbilt University. Started Dec 2015; status: completed.

02

Drugs

atorvastatinamlodipinelosartanhydrochlorothiazide
03

Conditions

hypertension (HTN)hyperlipidemia

Beyond the preview

Go deeper on NCT02278471.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02278471.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call